1. Chronic Insomnia in Kidney Transplant Recipients
Marta Novak, MD, PhD, Miklos Zs. Molnar, MD, PhD, Csaba Ambrus, MD, Agnes Zs. Kovacs, Agnes Koczy, Adam Remport, MD, Lilla Szeifert, Andras Szentkiralyi, MD, Colin M. Shapiro, MD, PhD, Maria S. Kopp, MD, PhD, DSc, Istvan Mucsi, MD, PhD 
American Journal of Kidney Diseases 
Volume 47, Issue 4, Pages (April 2006)
DOI: /j.ajkd
Copyright © 2006 National Kidney Foundation, Inc. Terms and Conditions

2. Fig 1
(A) Prevalence of insomnia symptoms in the 3 populations. *Significant difference (P < 0.01) between the wait-listed (WL) versus transplant (Tx) groups and WL versus general-population (Gp) groups, but not between the Tx versus Gp groups. **Significant difference among all 3 groups (P < 0.001). (B) Prevalence of daytime consequences of impaired sleep in the 3 populations. *Significant difference (P < 0.01) between the WL versus Tx and WL versus Gp populations, but not between the Tx versus Gp groups. **Significant difference among all 3 groups.
American Journal of Kidney Diseases  , DOI: ( /j.ajkd )
Copyright © 2006 National Kidney Foundation, Inc. Terms and Conditions